Related Articles
Impact of chemotherapy on the expression of claudins and cadherins in invasive breast cancer
FGFR1 and HER1 or HER2 co‑amplification in breast cancer indicate poor prognosis
Elevated tumor mutation burden and immunogenic activity in patients with hormone receptor‑negative or human epidermal growth factor receptor 2‑positive breast cancer
Novel treatment strategies for patients with HER2‑positive breast cancer who do not benefit from current targeted therapy drugs (Review)
Joint detection of multiple immunohistochemical indices and clinical significance in breast cancer